A review and update of red yeast rice

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 17, Issue 1, 2012, Pages 33-39

  Musselman, Megan E ^a   Pettit, Rebecca S ^b   Derenski, Karrie L ^c  

^a Saint Luke's Health System Missouri   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

^c Ferrell Duncan Clinic   (United States)

Author keywords

cholesterol; dyslipidemia; monacolins; Monascus purpureus; polyketides; red yeast rice; statins

Indexed keywords

EID: 84855387078     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: 10.1177/2156587211429703     Document Type: Review

References (50)

1. Ma J,Li Y,Ye Q, et al.Constituents of red yeast rice, a traditional Chinese food and medicine.J Agric Food Chem. 2000;48:5220-5225.
2. Nijjar PS,Burke FM,Bloesch A,Rader DJ.Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review.J Clin Lipidol. 2010;4:248-258.
3. Heber D,Lembertas A,Lu QY,Bowerman S,Go VL.An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.J Altern Complement Med. 2001;7:133-139.
4. Liu J,Zhang J,Shi Y,Grimsgaard S,Alraek T,Fonnebo V.Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.Chin Med. 2006;:1-4.
5. Alberts AW,Chen J,Kuron G, et al.Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proc Natl Acad Sci U S A. 1980;77:3957-3961.
6. ConsumerLab.com Page. https://www.consumerlab.com/reviews/Red-Yeast-Rice-Supplements-Review/Red_Yeast_Rice/. Updated May 20, 2011. Accessed October 14, 2011.
7. Journoud M,Jones PJ.Red yeast rice: a new hypolipidemic drug.Life Sci. 2004;74:2675-2683.
8. Ma KY,Zhang ZS,Zhao SX, et al.Red yeast rice increases excretion of bile acids in hamsters.Biomed Environ Sci. 2009;22:269-277.
9. Heber D,Yip I,Ashley JM,Elashoff DA,Elashoff RM,Go VL.Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.Am J Clin Nutr. 1999;69:231-236.
10. Lin CC,Li TC,Lai MM.Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia.Eur J Endocrinol. 2005;153:679-686.
11. Bogsrud MP,Ose L,Langslet G, et al.HypoCol (red yeast rice) lowers plasma cholesterol: a randomized placebo controlled study.Scand Cardiovasc J. 2010;44:197-200.
12. Becker DJ,Gordon RY,Morris PB, et al.Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial.Mayo Clin Proc. 2008;83:758-764.
13. Halbert SC,French B,Gordon RY, et al.Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.Am J Cardiol. 2010;105:198-204.
14. Becker DJ,Gordon RY,Halbert SC,French B,Morris PB,Rader DJ.Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.Ann Intern Med. 2009;150:830-839, W147-W149.
15. Venero CV,Venero JV,Wortham DC,Thompson PD.Lipid-lowering efficacy of red yeast rice in a population intolerant to statins.Am J Cardiol. 2010;105:664-666.
16. Liu L,Zhao SP,Cheng YC,Li YL.Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.Clin Chem. 2003;49:1347-1352.
17. Lu Z,Kou W,Du B, et al.Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.Am J Cardiol. 2008;101:1689-1693.
18. Ye P,Lu ZL,Du BM, et al.Effect of Xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.J Am Geriatr Soc. 2007;55:1015-1022.
19. Zhao SP,Lu ZL,Du BM, et al.Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).J Cardiovasc Pharmacol. 2007;49:81-84.
20. Ye P,Wu CE,Sheng L,Li H.Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.J Altern Complement Med. 2009;15:719-725.
21. Li JJ,Lu ZL,Kou WR, et al.Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).J Clin Pharmacol. 2009;49:947-956.
22. Grieco A,Miele L,Pompili M, et al.Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all.J Hepatol. 2009;50:1273-1277.
23. Polsani VR,Jones PH,Ballantyne CM,Nambi V.A case report of myopathy from consumption of red yeast rice.J Clin Lipidol. 2008;2:60-62.
24. Roselle H,Ekatan A,Tzeng J,Sapienza M,Kocher J.Symptomatic hepatitis associated with the use of herbal red yeast rice.Ann Intern Med. 2008;149:516-517.
25. Vercelli L,Mongini T,Olivero N,Rodolico C,Musumeci O,Palmucci L.Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment.J Am Geriatr Soc. 2006;54:718-720.
26. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: Department of Health and Human Services; 2011:.
27. Su CF,Liu IM,Cheng JT.Improvement of insulin resistance by Hon-Chi in fructose-rich chow-fed rats.Food Chem. 2007;104:45-52.
28. Chen CC,Liu IM.Release of acetylcholine by Hon-Chi to raise insulin secretion in Wistar rats.Neurosci Lett. 2006;404:117-121.
29. Hsieh PS,Tai YH.Aqueous extract of Monascus purpureus M9011 prevents and reverses fructose-induced hypertension in rats.J Agric Food Chem. 2003;51:3945-3950.
30. Xue-Mei LX-HS,Zhen-Wen D,Shu-Ren G.Advances on the pharmacological effects of red yeast rice.Chin J Nat Med. 2011;9:161-166.
31. Kuba MTK,Sesoko M,Inoue F,Yasuda M.Angiotensin I-converting enzyme inhibitory peptides in red-mold rice made by Monascus purpureus.Process Biochem. 2009;44:1139-1143.
32. Jeon T,Hwang SG,Hirai S, et al.Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells.Life Sci. 2004;75:3195-3203.
33. Chen WP,Ho BY,Lee CL,Lee CH,Pan TM.Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet.Int J Obes (Lond). 2008;32:1694-1704.
34. Hossain CF,Okuyama E,Yamazaki M.A new series of coumarin derivatives having monoamine oxidase inhibitory activity from Monascus anka.Chem Pharm Bull (Tokyo). 1996;44:1535-1539.
35. Wong RW,Rabie B.Chinese red yeast rice (Monascus purpureus-fermented rice) promotes bone formation.Chin Med. 2008;3:4.
36. Cho YE,Alcantara E,Kumaran S, et al.Red yeast rice stimulates osteoblast proliferation and increases alkaline phosphatase activity in MC3T3-E1 cells.Nutr Res. 2010;30:501-510.
37. Gutierrez GE,Mundy B,Rossini G,Garrett IR,Chen ST,Mundy GR.Red yeast rice stimulates bone formation in rats.Nutr Res. 2006;26:124-129.
38. Poynter JN,Gruber SB,Higgins PD, et al.Statins and the risk of colorectal cancer.N Engl J Med. 2005;352:2184-2192.
39. Hong MY,Seeram NP,Zhang Y,Heber D.Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression.J Med Food. 2008;11:657-666.
40. Hong MY,Seeram NP,Zhang Y,Heber D.Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells.J Nutr Biochem. 2008;19:448-458.
41. Hong MY,Henning S,Moro A,Seeram NP,Zhang Y,Heber D.Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.Cancer Prev Res (Phila). 2011;4:608-615.
42. Moyad MA,Klotz LH.Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement.Urol Clin North Am. 2011;38:325-331.
43. Su NW,Lin YL,Lee MH,Ho CY.Ankaflavin from Monascus-fermented red rice exhibits selective cytotoxic effect and induces cell death on Hep G2 cells.J Agric Food Chem. 2005;53:1949-1954.
44. Akihisa T,Tokuda H,Yasukawa K, et al.Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects.J Agric Food Chem. 2005;53:562-565.
45. Ho BY,Pan TM.The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells.J Agric Food Chem. 2009;57:8258-8265.
46. Taira J,Miyagi C,Aniya Y.Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation.Biochem Pharmacol. 2002;63:1019-1026.
47. Aniya Y,Ohtani II,Higa T, et al.Dimerumic acid as an antioxidant of the mold Monascus anka.Free Radic Biol Med. 2000;28:999-1004.
48. Akihisa T,Tokuda H,Ukiya M, et al.Anti-tumor-initiating effects of monascin, an azaphilonoid pigment from the extract of Monascus pilosus fermented rice (red-mold rice).Chem Biodivers. 2005;2:1305-1309.
49. Lee CL,Wang JJ,Pan TM.Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and antioxidative effect.Appl Microbiol Biotechnol. 2008;79:829-841.
50. Lee CL,Kuo TF,Wu CL,Wang JJ,Pan TM.Red mold rice promotes neuroprotective sAPPalpha secretion instead of Alzheimer's risk factors and amyloid beta expression in hyperlipidemic Abeta40-infused rats.J Agric Food Chem. 2010;58:2230-2238.